Transplantation News: Breaking Transplantation News, Comments and Articles.

American Cancer Society to Recognize Industry Leaders at Annual Financial Services Cares Gala

-- Gala will take place Monday, June 24, 2013, at Cipriani 42nd Street, New York (Register here: http://cog.to/14eXevw) -- Eighth annual event will honor Dr. Andrew L. Kung and PIMCO for their continued commitment to cancer awareness and research The American Cancer Society announced today it will be hosting the

Elbit Imaging Announces Receipt of Notices from Bank Leumi - Update

TEL AVIV, Israel, May 21, 2013 /PRNewswire/ -- Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcement dated March 20, 2013, that it has received a notice from Bank Leumi le-Israel B.M. (the "Bank"), which the Company vigorously reject, stating that the Bank plans to exercise its rights to withdraw the securities deposited by the Com...

BrainStorm Provides Update on Clinical Trial and Scientific Conference Activities

NEW YORK, NY and PETACH TIKVAH, ISRAEL -- (Marketwired) -- 05/21/13 -- BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today provided an update on the company's current and upcoming clinical trial and scientific conference activities. Clinical Trial Activities Brainstorm recently performed the 5th transplantation in...

Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR

Diabetes Research Institute Foundation President and CEO Robert A. Pearlman Stepping Down After 20 Years

HOLLYWOOD, Fla., May 20, 2013 /PRNewswire-USNewswire/ -- After successfully leading the Diabetes Research Institute Foundation (DRIF) for two decades, Robert A. Pearlman, 67, of Boca Raton, FL, announced that he will be stepping down from his position as president and CEO effective June 30, 2013. (Photo: http://photos.prnewswire.com/prnh/20130520/DC17414) (Logo: http://photos.prnewswi...

RTI Donor Services New Florida Division Will Offer Option of Tissue Donation to Families Throughout Florida

RTI Donor Services, a not-for-profit tissue recovery network, announced today the opening of a new Florida division working with hospitals and medical examiners in Florida to provide the opportunity of tissue donation to more families after the loss of their loved ones. As a member of Donate Life Florida, RTI supports Florida’s organ, tissue and eye dona...

Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania

ROCKVILLE, Md., May 20, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported that Eva Feldman, MD, PhD, principal investigator, presented updated Phase I data from its spinal cord-derived human neural stem cell (NSI-566) trial in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) at the neuro diabetes special medical symposium in Bucharest,...

Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color

CHAMPAIGN, Ill., May 17, 2013 /PRNewswire/ -- Sony Biotechnology Inc. ("Sony") today announced the launch of the new Sony SP6800 Spectral Analyzer (SP6800).  Sony will be exhibiting and taking orders for this system at CYTO 2013, which will be held at the San Diego Convention Center in San Diego, California, from May 20 - 22.  The SP6800 Spectral Analyzer is Sony's second analytic...

Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to Improve Tacrolimus-Induced Tremors

HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro™ to improve tacrolimus-induced tremors in stable kidney transplant patients.  The study, Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO™ (STRATO) clinical trial, was presented a...

Revitalising renal care: Diaverum at ERA/EDTA 2013 in Istanbul

Renal care provider presents service portfolio at European event and results of ORAL-D study Diaverum, one of the world’s leading renal care service providers, is presenting its service portfolio and the results of its latest research at the ERA/EDTA 2013. The company provides renal care to 22,000 patients in 265 kidney centres in 18 countries across...

Robotic transplantation may reduce health disparities for obese patients with chronic kidney failure

Obese patients who received robotic kidney transplants had fewer wound complications than patients who received traditional "open" transplant surgery, according to surgeons at the University of Illinois Hospital & Health Sciences System.

Global Multiple Sclerosis Drugs Market Research Report Submitted by Transparency Market Research

Albany, NY, May 17, 2013 --(PR.com)-- Multiple sclerosis (MS) is an inflammation of fatty myelin sheaths around the axons of the brain and spinal cord. MS tends to affect the ability of nerve cells to communicate with each other in the brain and spinal cord. MS affects people with random symptoms based on the location and severity of attack. One event can last for days, weeks or months and can af...

Electronic Chemical Market Research Report Submitted by Transparency Market Research

Albany, NY, May 17, 2013 --(PR.com)-- Multiple sclerosis (MS) is an inflammation of fatty myelin sheaths around the axons of the brain and spinal cord. MS tends to affect the ability of nerve cells to communicate with each other in the brain and spinal cord. MS affects people with random symptoms based on the location and severity of attack. One event can last for days, weeks or months and can af...

[News] Platelet prophylaxis for haematological cancers

A recent study showed that prophylactic platelet transfusions to prevent bleeding in patients with haematological cancers should not be omitted. Simon Stanworth (Oxford University Hospitals NHS Trust, UK) and colleagues enrolled 600 patients receivi...

Robotic Kidney Transplants May Be Best Option For Obese Patients

Obese patients who received robotic kidney transplants had fewer wound complications than patients who received traditional "open" transplant surgery, according to surgeons at the University of Illinois Hospital & Health Sciences System. The findings...

World Congress on Interventional Oncology to Present Live TheraSphere® Administration

Interventional Oncology Team at Northwestern Memorial Hospital to performhepatocellular carcinoma liver-directed treatment with live narration Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, today announced that for the second consecutive year, organizer...

HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast

FRAMINGHAM, Mass. and SYDNEY, May 16, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2013 UBS Global Healthcare Conference at 11:00 a.m...

Dr. Jack Copeland Honored with Pioneer in Transplantation Award at ISHLT

SynCardia Co-Founder Recognized for His Landmark Contributions in the Field of Heart Transplantation Tucson, Ariz. (PRWEB) May 16, 2013 SynCardia Systems, Inc. (http://www.syncardia.com), manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that world-renowned heart surgeon and SynCardia co-founder Jack G. Copeland, MD, w...

New Stem Cell Growth Strategy Could Yield Better Way to Treat Brain Lesions

In a study just published in STEM CELLS Translational Medicine, researchers have found a new way to increase the survival of stem cells injected into the brain. The discovery might one day prove useful in developing new treatments for neurological disorders — especially brain lesions, which among other things can provoke seizures and indicate multiple sclerosis or certain forms of cancer. Durham...

Nevada Donor Network Announces Unprecedented Growth In Organ & Tissue Donation

LAS VEGAS, May 16, 2013 /PRNewswire/ -- Nevada Donor Network is proud to announce record breaking increases in all aspects of organ and tissue donation. Our staff facilitated donations from 75 organ donors, 296 tissue donors and 546 cornea donors during 2012. The 42% year over year rise in donation activity resulted in a 37% increase in the number of lifesaving organs for transplantation. The reco...

ACT Confirms Clinical Trial Participant Showed Improvement in Vision from 20/400 to 20/40 Following Treatment

Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative medicine, today confirmed that the vision of a patient enrolled in a clinical investigation of the company’s retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) has improved from 20/400 to 20/40 following treatment. The improv...

SynCardia Co-Founder Honored with Pioneer in Transplantation Award at ISHLT

TUCSON, Ariz., May 16, 2013 /PRNewswire/ -- SynCardia Systems, Inc. (www.syncardia.com), manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that world-renowned heart surgeon and SynCardia co-founder Jack G. Copeland, MD, was awarded the prestigious Pioneer in Transplantation Award at the annual meeting of the International...

Ambit Biosciences Announces Pricing of Initial Public Offering

SAN DIEGO, May 16, 2013 /PRNewswire/ -- Ambit Biosciences Corporation today announced the pricing of its initial public offering of 8,125,000 shares of its common stock at $8.00 per share.  Ambit has granted the underwriters a 30-day option to purchase up to an additional 1,218,750 shares at the initial public offering price to cover over-allotments, if any.  Ambit's common stock is...

TaiGen Biotechnology Announces Submission of New Drug Application for Nemonoxacin in Taiwan and Mainland China

TAIPEI, Taiwan, May 16, 2013 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") today announced that they have submitted New Drug Application (NDA) for the oral formulation of nemonoxacin with the Taiwan Food and Drug Administration (TFDA) and China Food and Drug Administration (CFDA). Approval is expected in the first half of 2014. Nemonoxacin is the first pharmaceutical produc...

NIH Saves Lives: Fred Hutchinson Cancer Research Center Calls On Congress To Restore Full NIH Funding

WASHINGTON, May 15, 2013 /PRNewswire/ -- Fred Hutchinson Cancer Research Center, one of the nation's top cancer research and prevention centers and pioneer of bone marrow and stem cell transplantation, today called on Congress to support restoring full funding to the National Institutes of Health (NIH), which supports pioneering research that saves lives. Funding was recently cut due to sequestrat...